Difference between revisions of "Flutamide (Eulexin)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
m |
||
| Line 15: | Line 15: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
* 1/27/1989: Initial FDA approval | * 1/27/1989: Initial FDA approval | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand names:''' Cytomid, Eulexin, Flutamid, Flutatec, Lutamide, Proscan, Tamid | ||
==References== | ==References== | ||
| Line 24: | Line 27: | ||
[[Category:Endocrine therapy]] | [[Category:Endocrine therapy]] | ||
[[Category:Antiandrogens]] | [[Category:Antiandrogens]] | ||
| + | [[Category:Nonsteroidal androgen receptor inhibitors]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
[[Category:Drugs FDA approved in 1989]] | [[Category:Drugs FDA approved in 1989]] | ||
Revision as of 16:06, 29 March 2018
General information
Class/mechanism: Antiandrogen; non-steroidal. Inhibits androgen uptake and/or inhibits nuclear binding of androgen in target tissues.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Flutamide (Eulexin) patient drug information (Chemocare)[3]
- Flutamide (Eulexin) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 1/27/1989: Initial FDA approval
Also known as
- Brand names: Cytomid, Eulexin, Flutamid, Flutatec, Lutamide, Proscan, Tamid